- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Norwegian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
1
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VISTN | NOK 23.70 | 0% | 5.3% | NOK 1.1b | n/a | PE16.7x | n/a | 5.3% |
Page 1 of 1